Tris-(2-hydroxyethyl)ammonium 2-methyl- and 2-methyl-4-chlorophenoxyacetate serve as effective inhibitors of thrombocyte aggregation and antioxidants.
Mirskova
A N
AN
Russian Academy of Sciences, Irkutsk, Russia.
Adamovich
S N
SN
Mirskov
R G
RG
Voronkov
M G
MG
D000975:Antioxidants / Q000737:chemistry / Q000494:pharmacology*; D001792:Blood Platelets / Q000187:drug effects / Q000378:metabolism; D006801:Humans; D066298:In Vitro Techniques; D015227:Lipid Peroxidation / Q000187:drug effects; D010642:Phenoxyacetates / Q000737:chemistry / Q000494:pharmacology*; D010974:Platelet Aggregation / Q000187:drug effects; D010975:Platelet Aggregation Inhibitors / Q000737:chemistry / Q000494:pharmacology*; D000644:Quaternary Ammonium Compounds / Q000737:chemistry / Q000494:pharmacology*
D000975:Antioxidants; D010642:Phenoxyacetates; D010975:Platelet Aggregation Inhibitors; D000644:Quaternary Ammonium Compounds; C473968:chlorocresacine; C473969:trecresanum